Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04666701

Efficacy and Safety of Escócia Association in the Treatment of Acute Pain

National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Escócia Association in the Treatment of Acute Pain

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
EMS · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Escócia association in adults with acute pain.

Conditions

Interventions

TypeNameDescription
DRUGEscócia associationEscócia association tablet
OTHERPlacebo KetorolacPlacebo Ketorolac tablet
OTHERPlacebo ScopolaminePlacebo Scopolamine dragee
DRUGKetorolac TromethamineKetorolac tablet
DRUGScopolamineScopolamine dragee
OTHERPlacebo Escócia associationPlacebo Escócia association tablet

Timeline

Start date
2023-02-01
Primary completion
2025-02-01
Completion
2025-06-01
First posted
2020-12-14
Last updated
2023-09-08

Source: ClinicalTrials.gov record NCT04666701. Inclusion in this directory is not an endorsement.